Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-23 4:29 pm Purchase | 13D | Heliogen Inc. HLGN | Cambridge Equities LP | 1,455,593 24.630% | 1,455,593 (New Position) | View |
| 2024-01-03 9:59 pm Purchase | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 696,162,179 83.500% | 45,949,213 (+7.07%) | View |
| 2023-09-21 4:25 pm Purchase | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 650,212,966 82.800% | 265,465,303 (+69.00%) | View |
| 2023-05-22 7:15 pm Purchase | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 384,747,663 77.300% | 14,991,427 (+4.05%) | View |
| 2022-12-06 8:28 pm Purchase | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 369,756,236 80.900% | 55,598,591 (+17.70%) | View |
| 2021-03-12 2:59 pm Purchase | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 314,157,645 81.900% | 314,157,645 (New Position) | View |
| 2020-12-21 10:58 am Unchanged | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 70,844,890 64.700% | 0 (Unchanged) | View |
| 2020-06-29 7:09 pm Purchase | 13D | ImmunityBio Inc. IBRX | Cambridge Equities LP | 70,844,890 65.600% | 3,710,000 (+5.53%) | View |